Key result
Minimally invasive edge-to-edge repair for Barlow's disease resulted in similar 12-year rates of recurrent mitral regurgitation ≥3+ compared to conventional sternotomy (5% vs 7%; P=0.30).
Why the study?
Does minimally invasive edge-to-edge repair provide comparable long-term results to conventional sternotomy in patients with severe mitral regurgitation due to Barlow's disease?
Cohort (n=208)
Does minimally invasive edge-to-edge repair provide comparable long-term results to conventional sternotomy in patients with severe mitral regurgitation due to Barlow's disease?
Absolute Event Rate: 5% vs 7%
p-value: p=0.30
Minimally invasive edge-to-edge repair for Barlow's disease offers excellent long-term durability and effectiveness comparable to conventional sternotomy.
Supports similar durability of minimally invasive repair in Barlow's disease; leaves open need for randomized confirmation.
OBJECTIVES: To evaluate whether the adoption of a right minithoracotomy operative approach had an impact on the long-term results of edge-to-edge (EE) repair compared to conventional sternotomy in patients with Barlow's disease and bileaflet prolapse. METHODS: We assessed the long-term results of 104 patients with Barlow's disease treated with a minimally invasive EE technique. An equal number of patients had a conventional median sternotomy EE repair for the same disease and were used as a control group. The inverse probability of treatment weighting was used to create comparable distributions of the covariates that were significantly different at baseline in the two groups. We performed a comparative analysis of the groups. RESULTS: No hospital deaths were observed. Follow-up was 99.5% complete (median 11.3 years). The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk, showed no difference between the two groups ( P = 0.87). At 12 years, the CIF of recurrent MR ≥ 3+, with death as the competing risk, was 7% in the sternotomy group and 5% in the minimally invasive group ( P = 0.30), and the CIF of recurrence of MR ≥ 2+ was 15 and 14%, respectively ( P = 0.63). The type of surgical approach was not a predictor of cardiac death, reoperation, recurrent MR ≥ 3+ or recurrent MR ≥ 2+. CONCLUSIONS: A minimally invasive approach does not have a negative impact on the effectiveness and long-term durability of the EE repair for bileaflet prolapse in Barlow's disease. Long-term outcomes are excellent, and valvular performance remains stable over time with no evidence of mitral stenosis.
No takes yet. Share an insight, caveat, or question.
Bonis et al. (2017) conducted a cohort in Severe mitral regurgitation due to bileaflet prolapse in Barlow's disease (n=208). Minimally invasive right minithoracotomy edge-to-edge repair vs. Conventional median sternotomy edge-to-edge repair was evaluated on Recurrent mitral regurgitation ≥ 3+ at 12 years (p=0.30). Minimally invasive edge-to-edge repair for Barlow's disease resulted in similar 12-year rates of recurrent mitral regurgitation ≥3+ compared to conventional sternotomy (5% vs 7%; P=0.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: